OrphAI Therapeutics
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) (NCT05798923) | OrphAI Therapeutics | 2023-08-30 |
| Study of Safety, Tolerability, and Biological Activity of LAM-002A in C9ORF72-Associated Amyotrophic Lateral Sclerosis (NCT05163886) | OrphAI Therapeutics | 2021-12-23 |
| A Study of LAM-003 in Patients With Acute Myeloid Leukemia (NCT03426605) | OrphAI Therapeutics | 2018-01-16 |
Track OrphAI Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.